SLN Earnings Silence Therapeutics Plc
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | -0.11 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.63 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -0.54 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.39 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.20 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -0.33 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -0.42 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.16 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.02 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -0.49 | 2025-02-27 | 10-K |
| FY 2024 | 2022-12-31 | -0.52 | 2025-02-27 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.